Status:
COMPLETED
COVID-19: Human Epidemiology and Response to SARS-CoV-2
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
Rho Federal Systems Division, Inc.
Conditions:
Coronavirus Disease 2019 (COVID-19)
SARS-CoV-2
Eligibility:
All Genders
Brief Summary
The human disease caused by SARS-CoV-2 is called COVID-19. In most cases, COVID-19 presents as a mild to moderate respiratory illness. But it can also be more severe and even lead to death. The purpo...
Detailed Description
The study population will include children that are participants in NIH-funded cohort studies and their families (household contacts).The intent is to recruit families that have experience with the co...
Eligibility Criteria
Inclusion
- Household members who meet all of the following criteria are eligible for enrollment as study participants:
- The index participant, defined as an individual who either is or has been a participant in an NIH-funded clinical research study from which information on respiratory conditions, including asthma, and other atopic and allergic diseases is available, is:
- ≤21 years of age, and
- Lives with caregiver(s).
- The index participant and/or caregiver understands the study procedures and is willing to conduct these procedures at home;
- Have the ability to use either a computer or a smart phone to link to and respond to the study questionnaires:
- -Exception: When the family is willing to speak with a study member to answer the questionnaires in the event of not having access to a computer or a smart phone.
- The index participant and caregiver will reside in the United States, including Puerto Rico, for the duration of the study;
- The index participant will live with the caregiver for at least 50% of the time for the duration of the study;
- An English or Spanish speaker is available to:
- Serve as the primary contact, and
- As the person who will be responsible for the completion of questionnaires and the collection of study biological samples; and,
- To participate as a sibling (of the index participant), must be under 21 years of age and live in the same home as the index participant and caregiver.
Exclusion
- Past or current medical problems, which, in the opinion of the site investigator may:
- Pose risks from participation in the study
- Interfere with the participant's ability to comply with study requirements, or
- Impact the quality or interpretation of the data obtained from the study.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2021
Estimated Enrollment :
5599 Patients enrolled
Trial Details
Trial ID
NCT04375761
Start Date
May 1 2020
End Date
March 29 2021
Last Update
August 6 2025
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital Colorado: Inner City Asthma Consortium (ICAC) Site
Aurora, Colorado, United States, 80045
2
Children's Hospital Colorado: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site
Aurora, Colorado, United States, 80045
3
Children's National Medical Center: Inner City Asthma Consortium (ICAC) Site
Washington D.C., District of Columbia, United States, 20010
4
Ann & Robert H. Lurie Children's Hospital of Chicago: Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD) and Improving Technology-Assisted Recording of Asthma Control in Children (iTRACC) Site
Chicago, Illinois, United States, 60611